GLUT1 deficiency syndrome 2013: current state of the art
about
Glycogen metabolism in humansObtaining genetic testing in pediatric epilepsyTargeted Next Generation Sequencing in Patients with Inborn Errors of MetabolismWZB117 (2-Fluoro-6-(m-hydroxybenzoyloxy) Phenyl m-Hydroxybenzoate) Inhibits GLUT1-mediated Sugar Transport by Binding Reversibly at the Exofacial Sugar Binding Site.Diagnosis and Treatment of Childhood Migraine.Regulation of Monocarboxylic Acid Transporter 1 Trafficking by the Canonical Wnt/β-Catenin Pathway in Rat Brain Endothelial Cells Requires Cross-talk with Notch SignalingExogenous Ketone Supplements Reduce Anxiety-Related Behavior in Sprague-Dawley and Wistar Albino Glaxo/Rijswijk Rats.Glucose transport 1 deficiency presenting as infantile spasms with a mutation identified in exon 9 of SLC2A1.Brain correlates of spike and wave discharges in GLUT1 deficiency syndrome.The relationship between genes affecting the development of epilepsy and approaches to epilepsy therapy.Quantitative targeted proteomics for understanding the blood-brain barrier: towards pharmacoproteomics.Unusual phenotype of glucose transport protein type 1 deficiency syndrome: A case report and literature review.Paroxysmal dyskinesias revisited: a review of 500 genetically proven cases and a new classification.Personalized medicine approaches in epilepsy.Metabolic syndrome and the immunological affair with the blood-brain barrier.GLUT, SGLT, and SWEET: Structural and mechanistic investigations of the glucose transporters.Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery.The face of Glut1-DS patients: A 3D Craniofacial Morphometric Analysis.Atypical Manifestations in Glut1 Deficiency Syndrome.The changing face of dietary therapy for epilepsy.Ketogenic diet and childhood neurological disorders other than epilepsy: an overview.Pharmacogenomics in epilepsy.The epileptic and nonepileptic spectrum of paroxysmal dyskinesias: Channelopathies, synaptopathies, and transportopathies.Inborn Errors of Metabolism and Epilepsy: Current Understanding, Diagnosis, and Treatment Approaches.Ghrelin Regulates Glucose and Glutamate Transporters in Hypothalamic Astrocytes.Treatment of Epileptic Encephalopathies: Current State of the Art.Gene therapy for a mouse model of glucose transporter-1 deficiency syndrome.The ketogenic diet is not feasible as a therapy in a CD-1 nu/nu mouse model of renal cell carcinoma with features of Stauffer's syndrome.Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease.A Different SLC2A1 Gene Mutation in Glut 1 Deficiency Syndrome: c.734A>C.Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1)Individualizing Treatment Approaches for Epileptic Patients with Glucose Transporter Type1 (GLUT-1) Deficiency.Use of modified Atkins diet in glucose transporter type 1 deficiency syndrome.Actual Insights into Treatable Inborn Errors of Metabolism Causing Epilepsy.Expanding the Spectrum of Dopa-Responsive Dystonia (DRD) and Proposal for New Definition: DRD, DRD-plus, and DRD Look-alike.
P2860
Q26751151-79392150-2BB4-40F9-ACB7-01EF00A5EE48Q28082549-C3738479-F6EE-4C94-83E8-B65C43CDAA2BQ28552518-04059730-06E8-4153-A7DB-EB23072D398CQ30395148-59BCCF7E-54FA-436E-9CFF-68B3C93B0A03Q34541963-D34A81ED-053F-42DF-8704-E75A9ADA2BDDQ36778818-12781913-2E1A-44D9-88D2-7E37BDF3C32FQ37475036-F901D869-E4A1-43AF-BC69-28F0DCF91E9BQ37525648-14436ECD-DE9F-4C65-8AF3-9B49C62DE7EDQ37584230-6994C554-BC8D-4648-AB1F-11BB989449D9Q38187700-7A6A526A-5CCC-4E1F-BA7E-863D5554C1EDQ38202164-3FFA45FD-8EF8-4374-85EB-F14A8DE20E53Q38217229-EBA32B5A-01B6-4B06-8B4E-62552C400933Q38223128-AD9AD28C-9A5A-41A8-99B0-9F51003670FEQ38262011-3674F39E-12C5-40B7-9F84-CF4710336A20Q38324539-9E8100F9-1C61-4E34-AAD1-798BA39F9AEBQ38663958-6C92364D-7EA6-4DFE-A7FE-AC29D5B5FABAQ38708393-97A63DD1-A06B-487D-A8DB-1D2382F6A578Q38811505-9786C5E3-AE57-4B2F-9E17-5B9A4B36A3D0Q38850454-EE2C2224-F061-4B7A-91F2-B320DC80BA48Q38944219-A55CE820-1E3C-43EB-BB54-2138087881AAQ39007510-F9BCCCE4-1BD1-42DF-B54F-F63897BEF58DQ39084353-4502005F-6A5D-48A5-8291-62B711E0A23EQ39090098-FC7ABE6F-6887-409B-B3DE-2743F152ED27Q39411002-46D111C7-CA55-4443-BBE5-6D380B0D7A88Q39646578-8CF47140-EA56-49CC-B82F-8E286947BB0CQ40359639-EDA34C4A-FA45-449E-929A-7BDB04EE5FA0Q40365796-EDFC201E-87B2-457E-BD06-59D77592528FQ41342600-2C2C44E9-7839-487E-AB6D-4E72243AA9F3Q41660607-DC2DCBCE-BE27-49CE-B893-BBB8C79BF75AQ41919937-44D75B89-AFED-4167-B793-2B86E3DCC500Q45314506-20369D3E-7F66-45F5-B13C-FD4CB66A734DQ47882020-47D55AC2-257F-4B96-88D7-721AA8E131DBQ48690341-0122316E-775E-4A5D-98D4-4AAC00FDFA0EQ55097743-7C2F47FA-44DD-49C6-B9CF-BACBCDEFED4BQ55507401-3D6A8629-0913-4247-98A4-22E599E3C703
P2860
GLUT1 deficiency syndrome 2013: current state of the art
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
GLUT1 deficiency syndrome 2013: current state of the art
@ast
GLUT1 deficiency syndrome 2013: current state of the art
@en
GLUT1 deficiency syndrome 2013: current state of the art
@nl
type
label
GLUT1 deficiency syndrome 2013: current state of the art
@ast
GLUT1 deficiency syndrome 2013: current state of the art
@en
GLUT1 deficiency syndrome 2013: current state of the art
@nl
prefLabel
GLUT1 deficiency syndrome 2013: current state of the art
@ast
GLUT1 deficiency syndrome 2013: current state of the art
@en
GLUT1 deficiency syndrome 2013: current state of the art
@nl
P3181
P1476
GLUT1 deficiency syndrome 2013: current state of the art
@en
P2093
Pierangelo Veggiotti
Valentina De Giorgis
P304
P3181
P356
10.1016/J.SEIZURE.2013.07.003
P407
P577
2013-12-01T00:00:00Z